Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma
Open Access
- 1 October 2003
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 8 (4), 552-558
- https://doi.org/10.1016/s1525-0016(03)00222-3
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hostsCancer Gene Therapy, 2003
- A Critical Role for IL-21 in Regulating Immunoglobulin ProductionScience, 2002
- In vivo evidence for a dependence on interleukin 15 for survival of natural killer cellsBlood, 2002
- Interleukin 21 Is a T Helper (Th) Cell 2 Cytokine that Specifically Inhibits the Differentiation of Naive Th Cells into Interferon γ–producing Th1 CellsThe Journal of Experimental Medicine, 2002
- Noninvasive gene delivery to the liver by mechanical massageHepatology, 2002
- IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent mannerGut, 2000
- THE MULTIFACETED REGULATION OF INTERLEUKIN-15 EXPRESSION AND THE ROLE OF THIS CYTOKINE IN NK CELL DIFFERENTIATION AND HOST RESPONSE TO INTRACELLULAR PATHOGENSAnnual Review of Immunology, 1999
- Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 ReceptorScience, 1994
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991
- Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cellsNature, 1985